Saturday, June 18, 2011 12:07:44 AM
#2- If accredited investors were willing to risk 1.8 million $ on shares at .90, I'd say that's a pretty nice vote of confidence. You don't buy shares at .90 if you think FDA approval is unlikely....simply because you know that if the FDA approval doesn't happen, your .90 shares will be trading at .27 before you can type in your sell order.
#3- This deal was cut weeks ago.....and no doubt leaks around the deal have contributed to the sell-down to current levels. The PPS has held its ground above .90 over the past couple of weeks, even in a horrific market.
The only real question left for me is how much approval is already baked into the PPS.....and as a long, I hope the answer is "not at all."
GLTY
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM